Efficacy and safety of recombinant human parathyroid hormone (1–84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study

Autor:	Mannstadt, Michael, Clarke, Bart L, Vokes, Tamara, Brandi, Maria Luisa, Ranganath, Lakshminarayan, Fraser, William D, Lakatos, Peter, Bajnok, Laszlo, Garceau, Roger, Mosekilde, Leif, Lagast, Hjalmar, Shoback, Dolores, Bilezikian, John P
Zdroj:	In The Lancet Diabetes & Endocrinology December 2013 1(4):275-283
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu